The earliest paper in the line of work behind Shasqi: an implanted material that pulls a matching small molecule out of the bloodstream by a click reaction.
The first author, who later founded Shasqi, gives the Department of Orthopaedic Surgery at the University of California, Davis, as his affiliation. The paper presents an implantable biomaterial that uses click chemistry in the body to enhance the delivery of suitable small molecules by an order of magnitude, and shows a polysaccharide being modified hours after it was implanted. The authors describe it as a first step towards a biomaterial that fixes where a systemically given small molecule ends up. It is not a cancer study.
It shows the capture step working in an animal before any drug was attached to the idea.
Shares Shasqi, Click-activated prodrugs (bioorthogonal drug activation in the body).
Shares Shasqi, Click-activated prodrugs (bioorthogonal drug activation in the body).
Shares Shasqi, Click-activated prodrugs (bioorthogonal drug activation in the body).
Shares Shasqi, Click-activated prodrugs (bioorthogonal drug activation in the body).
Shares Shasqi, Click-activated prodrugs (bioorthogonal drug activation in the body).
Shares Shasqi, Click-activated prodrugs (bioorthogonal drug activation in the body).
Shares Shasqi, Click-activated prodrugs (bioorthogonal drug activation in the body).
Shares Shasqi, Click-activated prodrugs (bioorthogonal drug activation in the body).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/